Cardiac arrest & resuscitation

Prehospital management of supraventricular tachycardia: a multicentre study of current practices with a subgroup propensity score-based comparison of adenosine and electrical cardioversion in unstable patients

ResuscitationPublished Retrospective cohort study

Main finding · Successful cardioversionResult — go to the resultWeighted odds ratio 2.41 95 % CI 1.01–7.14

Authors' conclusion

In patients with prehospital SVT, adenosine is the preferred cardioversion strategy. In unstable cases, adenosine may be a safe first-line attempt before ECV, potentially reducing sedation-related risks.

Study context

Population
Prehospital supraventricular tachycardia (SVT) events, three Italian physician-staffed Emergency Medical Services, 2019–2024
Participants
1,234 SVT events
Exposure
Adenosine vs electrical cardioversion for prehospital SVT
  • Adenosinen = 763reference
  • Electrical cardioversion (ECV)n = 56
Outcome
Rate of successful cardioversion
Methodological detailsmulticentre, propensity score-weighted
  • Multicentre
  • Propensity score-weighted

Main finding

Successful cardioversion

Weighted odds ratio

2.41

95 % CI 1.01–7.14

By group

ECV vs Adenosine
weighted OR 2.41 (95 % CI 1.01–7.14)

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

ECG diagnostic accuracy
90.7 %
Dangerous misdiagnosis (eg VT) in available ECG readings
fewer than 2 %

Safety

Events

OutcomeAdenosineECV
Life-threatening complications after cardioversion00

Life-threatening complications after cardioversion

More frequent sedative use with ECV vs adenosine

Original publication

Prehospital management of supraventricular tachycardia: a multicentre study of current practices with a subgroup propensity score-based comparison of adenosine and electrical cardioversion in unstable patients. Resuscitation. Published 7 July 2025. doi:10.1016/j.resuscitation.2025.110707

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.